NDLI: Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics

Content Provider	Springer Nature : BioMed Central
Author	Kamma, Emily Lasisi, Wendy Libner, Cole Ng, Huah Shin Plemel, Jason R.
Abstract	There are over 15 disease-modifying drugs that have been approved over the last 20 years for the treatment of relapsing–remitting multiple sclerosis (MS), but there are limited treatment options available for progressive MS. The development of new drugs for the treatment of progressive MS remains challenging as the pathophysiology of progressive MS is poorly understood.The progressive phase of MS is dominated by neurodegeneration and a heightened innate immune response with trapped immune cells behind a closed blood–brain barrier in the central nervous system. Here we review microglia and border-associated macrophages, which include perivascular, meningeal, and choroid plexus macrophages, during the progressive phase of MS. These cells are vital and are largely the basis to define lesion types in MS. We will review the evidence that reactive microglia and macrophages upregulate pro-inflammatory genes and downregulate homeostatic genes, that may promote neurodegeneration in progressive MS. We will also review the factors that regulate microglia and macrophage function during progressive MS, as well as potential toxic functions of these cells. Disease-modifying drugs that solely target microglia and macrophage in progressive MS are lacking. The recent treatment successes for progressive MS include include B-cell depletion therapies and sphingosine-1-phosphate receptor modulators. We will describe several therapies being evaluated as a potential treatment option for progressive MS, such as immunomodulatory therapies that can target myeloid cells or as a potential neuroprotective agent.
Related Links	https://jneuroinflammation.biomedcentral.com/counter/pdf/10.1186/s12974-022-02408-y.pdf
Ending Page	27
Page Count	27
Starting Page	1
File Format	HTM / HTML
ISSN	17422094
DOI	10.1186/s12974-022-02408-y
Journal	Journal of Neuroinflammation
Issue Number	1
Volume Number	19
Language	English
Publisher	BioMed Central
Publisher Date	2022-02-10
Access Restriction	Open
Subject Keyword	Neurosciences Neurology Neurobiology Immunology Macrophages Microglia Multiple sclerosis Neurodegeneration Primary progressive Secondary progressive Therapeutics
Content Type	Text
Resource Type	Review
Subject	Neuroscience Immunology Cellular and Molecular Neuroscience Neurology
Journal Impact Factor	9.3/2023
5-Year Journal Impact Factor	9.8/2023

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Border-associated macrophages in the central nervous system

Enhanced uptake of multiple sclerosis-derived myelin by THP-1 macrophages and primary human microglia

Systemic TLR2 tolerance enhances central nervous system remyelination

Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation

Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis

Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis

Fatty acids role in multiple sclerosis as “metabokines”

Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain

CD36-mediated uptake of myelin debris by macrophages and microglia reduces neuroinflammation

Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics

Similar Documents

Border-associated macrophages in the central nervous system

Enhanced uptake of multiple sclerosis-derived myelin by THP-1 macrophages and primary human microglia

Systemic TLR2 tolerance enhances central nervous system remyelination

Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation

Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis

Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis

Fatty acids role in multiple sclerosis as “metabokines”

Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain

CD36-mediated uptake of myelin debris by macrophages and microglia reduces neuroinflammation

Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics